Tumor-derived IL-6 increases VEGF expression in megakaryocytes, and consequent platelet VEGF levels also increased in platelet α-granules, suggesting a complex interplay between platelets and cancer cells in the regulation of tumor angiogenesis (67). Here, IL6 is linked to neoplasm.